| Robert Hamilton-seth, MD | |
|
Ms 3045, 3901 Rainbow Blvd, Kansas City, KS 66160-0001 | |
| (913) 588-7070 | |
| Not Available |
| Full Name | Robert Hamilton-seth |
|---|---|
| Gender | Male |
| Speciality | Pathology - Medical Microbiology |
| Location | Ms 3045, 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376047209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | 04-47953 (Kansas) | Secondary |
| 207ZM0300X | Pathology - Medical Microbiology | 04-47953 (Kansas) | Primary |
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Avita Medical Ltd., the regenerative medicine company, today announced that the United States Food and Drug Administration (FDA) has approved the Company's investigational device exemption (IDE) feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars: i.e., raised and/or discoloured scars.
Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted it patent number GB2460597 titled "N,N-Disubstituted aminoalkylBiPhenyl Antagonists OF Prostaglandin d2 RECEPTORS."
Medisafe 1 Technologies Corp., a developer of a U.S. patented technology that physically prevents unauthorized administration of prescription medications, announced today that the company has been granted eligibility status by the Depository Trust Company. The DTC provides banks, brokerage firms and other institutions with an efficient means of moving securities and settling trades electronically.
The U.S. Food and Drug Administration should apply the same rigor to evaluating the science behind claims of foods' and nutritional supplements' health benefits as it devotes to assessing medication and medical technology approvals, says a new report from the Institute of Medicine.
A combination of moderate weight loss and exercise is an effective treatment for overweight adults with osteoarthritis of the knee, according to new research from Wake Forest University published in the May issue of the journal Arthritis & Rheumatism.
› Verified 1 days ago
| Entity Name | University Of Kansas Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528019502 PECOS PAC ID: 9436054798 Enrollment ID: O20050908001103 |
News Archive
Avita Medical Ltd., the regenerative medicine company, today announced that the United States Food and Drug Administration (FDA) has approved the Company's investigational device exemption (IDE) feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars: i.e., raised and/or discoloured scars.
Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted it patent number GB2460597 titled "N,N-Disubstituted aminoalkylBiPhenyl Antagonists OF Prostaglandin d2 RECEPTORS."
Medisafe 1 Technologies Corp., a developer of a U.S. patented technology that physically prevents unauthorized administration of prescription medications, announced today that the company has been granted eligibility status by the Depository Trust Company. The DTC provides banks, brokerage firms and other institutions with an efficient means of moving securities and settling trades electronically.
The U.S. Food and Drug Administration should apply the same rigor to evaluating the science behind claims of foods' and nutritional supplements' health benefits as it devotes to assessing medication and medical technology approvals, says a new report from the Institute of Medicine.
A combination of moderate weight loss and exercise is an effective treatment for overweight adults with osteoarthritis of the knee, according to new research from Wake Forest University published in the May issue of the journal Arthritis & Rheumatism.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Hamilton-seth, MD Ms 3045, 3901 Rainbow Blvd, Kansas City, KS 66160-0001 Ph: (913) 588-7070 | Robert Hamilton-seth, MD Ms 3045, 3901 Rainbow Blvd, Kansas City, KS 66160-0001 Ph: (913) 588-7070 |
News Archive
Avita Medical Ltd., the regenerative medicine company, today announced that the United States Food and Drug Administration (FDA) has approved the Company's investigational device exemption (IDE) feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars: i.e., raised and/or discoloured scars.
Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted it patent number GB2460597 titled "N,N-Disubstituted aminoalkylBiPhenyl Antagonists OF Prostaglandin d2 RECEPTORS."
Medisafe 1 Technologies Corp., a developer of a U.S. patented technology that physically prevents unauthorized administration of prescription medications, announced today that the company has been granted eligibility status by the Depository Trust Company. The DTC provides banks, brokerage firms and other institutions with an efficient means of moving securities and settling trades electronically.
The U.S. Food and Drug Administration should apply the same rigor to evaluating the science behind claims of foods' and nutritional supplements' health benefits as it devotes to assessing medication and medical technology approvals, says a new report from the Institute of Medicine.
A combination of moderate weight loss and exercise is an effective treatment for overweight adults with osteoarthritis of the knee, according to new research from Wake Forest University published in the May issue of the journal Arthritis & Rheumatism.
› Verified 1 days ago
Dr. Mark T Cunningham, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Dept Of Pathology, Kansas City, KS 66160 Phone: 913-588-7070 Fax: 913-588-7073 | |
Anders Meyer, Pathology Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-7090 | |
Christopher Jurief, DO Pathology Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-945-7972 | |
Dr. Diane L Persons, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, Dept Of Pathology, Kansas City, KS 66160 Phone: 913-588-7070 Fax: 913-588-7073 | |
Dr. Zhan Ye, M.D., PH.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-1651 | |
Dr. Kathy L Newell, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Dept Of Pathology, Kansas City, KS 66160 Phone: 913-588-7070 Fax: 913-588-7073 | |
Maura Frances O'neil, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-7073 Fax: 913-588-7073 |